Feud Intensifies Between ‘Hypocritical’ Planned

New Post Public Reply Private Reply Replies (0) Message Board
PoemStone
137
Feud Intensifies Between ‘Hypocritical’
Planned Parenthood and Ousted Physician President
< >

Dr.-Leana-Wen-640x480.png


The public feud between Planned Parenthood and its recently ousted physician president is intensifying as Dr. Leana Wen accuses the left-wing organization of hypocrisy and attempted intimidation.

In a letter to Planned Parenthood’s board of directors that was obtained by the New York Times, the former president and CEO accused the group of holding her health insurance and severance pay as “ransom” until she agreed to sign a confidentiality agreement.

In the letter, Wen reportedly wrote, “I have no desire to file claims against Planned Parenthood for defamation, retaliation, or discrimination,” but then added that the organization was demanding she stop speaking publicly “in exchange for my contractually-guaranteed severance and continued health insurance coverage.”

Wen referred to Planned Parenthood’s actions as “unjust” and “unethical,” said the Times.

The battle between Wen and the abortion giant comes as Planned Parenthood has been more open that abortion is its central priority.

Though, for years, the group insisted abortion was a very small part of the “healthcare” services it provided, ultimately Planned Parenthood opted not to remain in the federal Title X family planning grant program when the Trump administration decided to enforce the program’s rule that grantees of the funds not refer for or perform abortions.

The organization abandoned the program, leaving about $60 million behind in federal funding that will now be redirected to federally qualified healthcare centers that do not perform abortions.

In her letter, Wen reportedly referred to the Trump administration’s Title X rule enforcement as she accused Planned Parenthood’s board of hypocrisy.

“It is deeply hypocritical,” she wrote, that her former organization, “would attempt to enforce a gag order on its immediate past President/CEO while fighting the Trump administration’s gag rule on Title X providers.”

According to the Times, Melanie Newman, senior vice president for communications at Planned Parenthood, said Wen’s accusations are “unfortunate, saddening, and simply untrue.”

“The attorneys representing the board have made every good faith effort to amicably part from Dr. Wen, and are disappointed that they have been unable to reach a suitable resolution regarding her exit package,” she added.

Newman claims Wen received in her severance package a full additional year of salary and health benefits “under terms that are standard and consistent with her employment agreement and any reasonable executive exit package.”

Nevertheless, Wen, who expressed disappointment in a Twitter post that her letter leaked out, said, “There should be no dispute regarding the terms of my employment contract, which are clearly spelled out.”

The ousted president’s tenure at Planned Parenthood lasted less than a year. At the time Wen was hired, the organization announced her as its choice for president with much fanfare that Planned Parenthood would have its first physician president in decades. The group gave the appearance of showing interest in developing its non-abortion services.

When she was suddenly fired in July, Wen at first referred in a tweet to the reason for her ouster as “philosophical differences” with the board, but then elaborated on that reference in a three-page letter to Planned Parenthood colleagues and supporters.

She explained:

One year ago, when I came in front of the Search Committee selecting Planned Parenthood’s next President, I posed this question: Did they see Planned Parenthood as an advocacy organization first, with medical services that are necessary to strengthen its impact, or did they see Planned Parenthood as a health care organization first, with advocacy as a necessary vehicle to protect rights and access?

Wen said she believed she was coming in as Planned Parenthood president to “run a national health care organization and to advocate for the broad range of public health policies that affect our patients’ health.”

“The new Board leadership has determined that the priority of Planned Parenthood moving forward is to double down on abortion rights advocacy,” she said.

According to the Times, Wen said in her letter she believed the best way to protect Planned Parenthood from the Trump administration and states eager to restrict abortion and cut the group’s funding would be to de-emphasize its abortion services.

“However,” she reportedly wrote, “there is a vocal minority,” including many national staff and board members, “who prefer a stridently political, abortion-first philosophy.”

The struggle between Wen and the Planned Parenthood organization became palpable in January after Wen’s interview with BuzzFeed News that was published with the headline, “Planned Parenthood’s New President Wants to Focus on Nonabortion Health Care.”

Following its publication, however, Wen tweeted the headline “completely misconstrue[d] my vision for Planned Parenthood.”

The physician then made what may be the most memorable announcement of her tenure at Planned Parenthood: Abortion is “our core mission.”

After Wen’s ouster, a report at Politico indicated a former Planned Parenthood employee denied the existence of “philosophical differences” between Wen and the board. The anonymous ex-staff member described Wen as an “incompetent manager” who had done significant “damage” to the organization.

At the time of Wen’s ouster, Troy Newman, president of pro-life group Operation Rescue, said the developing feud between Wen and Planned Parenthood was providing the country with “a glimpse of the disarray and division within Planned Parenthood’s ranks.”

“What we are seeing right now is a desperate attempt to regain political power it lost when President Trump took office in 2017,” he added. “They are willing to throw anyone and everyone under the bus to get that power back.”

Currently, Planned Parenthood still receives over $500 million in taxpayer funds as reimbursements through the Medicaid program.
Featured stocks: Coffee Shoppe
For conservative debate: "Keeping it Real"
Game Changing stock $SHMP

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Moon Base Ambitions: Impulse Space Wins Key NASA Contracts

Updated Category News Views 393

NASA's Vision and Impulse's New Role Ever think you'd see a company like Impulse Space set to play a starring role in humanity's return to the lunar surface? Well, strap in because this isn't just a pipe dream anymore. NASA's bold plan to establish a Moon Base has taken a tangible step forward with Impulse winning two hefty task orders. This ain't just peanuts—this duo...

Continue Reading
Invasive Procedures Don't Extend Life in Stable Heart Disease

Updated Category News Views 220

Challenging Longstanding Beliefs Today’s news from the heart research front might set a few cardiology heads spinning. We’ve got big-time findings out of the ISCHEMIA-EXTEND study, throwing more weight on the evidence pile that early invasive heart procedures for patients with stable coronary artery disease don’t actually extend your life. Managing care with a blend...

Continue Reading
Quantum Space Joins $185M NASA Lunar Transport Deal

Updated Category News Views 298

Quantum Space Bags a Chunk of NASA's Lunar Ambitions Alright, folks, buckle up because we're about to dive into the cosmos. Quantum Space just nabbed a sweet deal—a $185 million whopper of a contract from NASA's Moon Base Transportation program. This isn't chump change; it's a 25% slice for Quantum from the lot Arrow Science and Technology is heading. We're talking...

Continue Reading
TCL's Display Future: AI Meets Screens at DTC 2026

Updated Category News Views 110

Exploring New Horizons in Display Technology There's something brewing in Wuhan: a conference that’s shaping up like a tech enthusiast’s dream. This year, it's all about the symbiosis of cutting-edge tech and dazzling visuals as TCL CSOT gears up to unveil advancements at the Global Display Tech-Ecosystem Conference (DTC) 2026. If you're wondering whether this event...

Continue Reading
Aurora Innovation Faces Legal Heat Amid Delays

Updated Category News Views 150

Production Snags at Aurora Innovation Ah, investing – not for the faint-hearted. One day you're riding high, the next you're scraping by, and Aurora Innovation's (NASDAQ:AUR) investors just hit a rough patch. The autonomous trucking darling announced unexpected delays in its delivery schedule, sending shockwaves through its stock price and shaking investor confidence....

Continue Reading
Johnson & Johnson Unveils Promising PsA Treatment Data

Updated Category News Views 188

A Game-Changer in Psoriatic Arthritis Treatment? Johnson & Johnson just tossed a headline-grabbing bone into the world of psoriatic arthritis with their new ICOTYDE results. For anyone tangled in the chronic web of psoriatic arthritis, hearing about a potential new treatment like ICOTYDE comes with cautious hope. Between stiff joints and rashy skin, sufferers are often...

Continue Reading
Evaluating GLP-1 Telehealth? Key Questions to Consider

Updated Category News Views 331

Navigating the Landscape of GLP-1 Telehealth Providers In the sprawling jungle of telehealth options for GLP-1 care, it's easy to feel like you're drowning in sameness. Picture this: you land on a sleek page promising the moon and stars, but who knows what's behind the curtain? That's where seasoned advice comes in, like a compass in this murky digital forest. Meant, a...

Continue Reading
Off-Broadway Play 'DUST' Raises Autism Support Funds

Updated Category News Views 318

Here's the scoop: an Off-Broadway production just did something many big hitters can't pull off. 'DUST,' a show crafted like a love letter to the American West, managed to rustle up $30,000 for young adults grappled with autism. Partnering with no less than Yale's Cultural Autism Studies and the Ed Asner Family Center, this effort hit the mark in more ways than one. An...

Continue Reading
ecozy's Brezzano Switch: Brewing Simplicity at Home

Updated Category News Views 361

Breathe the aroma, sip the innovation. ecozy just threw their Brezzano Switch into the arena, and here's the deal: it's a no-nonsense, get-your-caffeine-fix kind of machine aimed at making your mornings simple without compromising on flavor. Unique Features of the Brezzano Switch So, what's cooking? Get this—it's not just any coffee contraption. Built sleek and compact,...

Continue Reading
Adding Fireplaces: Home Comfort or Construction Headache?

Updated Category News Views 227

Sizing Up the Installation Options Slapping a fireplace into a home sounds more like a pipe dream than a practical project for most folks. But according to fireplace whiz Jimmy Smith down in North Charleston, the times are a-changin'. These days, with advances in technology, homeowners can actually pull it off without collapsing their living room walls. Nitty-Gritty:...

Continue Reading

Top 5 Most Recently Viewed Articles

Carrier's $2.5 Million Commitment for Wildfire Relief Efforts

Updated Category News Views 244

Carrier's Generous Pledge for Wildfire Relief In a significant initiative aimed at supporting communities affected by wildfires, Carrier Global Corporation (NYSE: CARR), a leader in intelligent climate solutions, has announced its commitment to donate over $2.5 million worth of indoor air purifiers. This effort is specifically directed towards enhancing air quality for...

Continue Reading
Lundbeck Unveils New Insights on Multiple System Atrophy

Updated Category News Views 358

Lundbeck Reveals Insights into Multiple System Atrophy at International Congress VALBY, Denmark – H. Lundbeck A/S (Lundbeck) is set to present pivotal pipeline data and invaluable patient perspectives from the recent AMULET trial, highlighting amlenetug as a promising treatment for the rare neurological disorder known as multiple system atrophy (MSA). This significant...

Continue Reading
Keenova Therapeutics: A New Era for Mallinckrodt's Spin-Off

Updated Category News Views 599

Welcome to Keenova Therapeutics In an exciting announcement, Mallinckrodt plc has successfully completed the planned spin-off of its Par Health generic pharmaceuticals and sterile injectables businesses. As of now, the company will operate under the new name, Keenova Therapeutics, dedicating its efforts towards developing and delivering innovative therapies for patients...

Continue Reading
BlackRock, Inc. Increases Shareholding in Ageas to 7.78%

Updated Category News Views 154

Recent Financial Developments at Ageas In an important disclosure regarding financial transparency, BlackRock, Inc. has officially notified Ageas that it has exceeded the legal threshold of 5% ownership in the company, with its current shareholding reaching an impressive 7.78%. This notification was made in accordance with regulatory requirements aimed at maintaining...

Continue Reading
AKWEL Reports Revenue Decline in Nine-Month Financial Update

Updated Category News Views 48

Decline in Revenue for AKWEL in Recent Financial Update AKWEL, a key player in the automotive and heavy-vehicle parts market, has announced a notable decline in their financial performance for the first nine months of the year. The company, specializing in fluid management and structural parts for electric vehicles, has reported a consolidated revenue of €757.7 million,...

Continue Reading